News for HOOKIPA Pharma Inc. (HOOK)

Gilead Sciences Inc. (NASDAQ:GILD) has announced it will be taking over HOOKIPA Pharma Inc. (NASDAQ:HOOK) for a consideration of $10 million. Gilead Sciences Inc. (NASDAQ:GILD) commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. GILD is only purchasing HOOK’s antiviral programs, specifically the “HB-400” & “HB-500”. The company first […]

Key Highlights: Gilead Sciences is set to acquire two antiviral programs from HOOKIPA Pharma for up to $10 million. Analysts project a significant upside

HOOKIPA Pharma (HOOK) stock gains as Gilead Sciences agrees to acquire some of its antiviral assets for up to $10M. Read more here.

**media[545971]**

EcoR1 Capital, LLC (Trades, Portfolio)'s Recent Transaction with HOOKIPA Pharma Inc On December 31, 2024, EcoR1 Capital, LLC (Trades, Portfolio) executed a sign

**media[528000]**

**media[511320]**

HOOKIPA Pharma Announces Notice to Shareholders Regarding U.K. Disclosure Requirements

**media[506444]**

**media[503919]**

RBC Capital Markets has downgraded Hookipa Pharma (HOOK) to sector perform from outperform, citing the company's recently announced restructuring plan. Read more here.

Hookipa Pharma stock hits 52-week low at $2.62 amid market challenges

**media[462597]**

HOOKIPA Pharma's SWOT analysis: stock's potential in immunotherapy market

Generation Bio Co. (NASDAQ: GBIO) came out with a quarterly loss of $0.31 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.47 per share a year ago. These figures are adjusted for non-recurring items.

Director Dr. Malte Peters named Chief Executive Officer and Director Terry Coelho named Executive Vice President and Chief Financial OfficerCompany is...

THIS DOCUMENT IS IMPORTANT AND REQUIRES YOUR IMMEDIATE ATTENTION. If you are in any doubt as to the action to be taken, please seek your own financial advice from...

Shares of CarMax, Inc. (NYSE: KMX) moved higher during Thursday’s session following better-than-expected quarterly earnings.

The Dow Jones closed higher by over 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.